Submissions Open For The 2016 Reaxys PhD Prize

Recognizing the brightest young chemists of the future

New York, December 8, 2015

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced that submissions are now open for the 2016 Reaxys PhD Prize. Now in its seventh year, the Reaxys PhD Prize is open to talented PhD students or recent graduates conducting original and innovative research in chemistry that demonstrates excellence in methodology and approach. Since its introduction in 2010, the Prize has nurtured advances in chemistry by giving young chemists worldwide who have produced truly groundbreaking research the recognition and opportunities to both extend their network and share knowledge. 

The 2016 Prize is open to any student who is either currently in a chemistry PhD program or who completed their PhD after January 1, 2015. To apply a candidate needs to submit a published, peer-reviewed article, a CV (resumé); and a letter of recommendation from their PhD supervisor. With previous winners from Asia, Europe and the Americas, the 2016 winners could come from anywhere in the world. Finalists for the Prize will join the Reaxys Prize Club, a unique, international network of chemists from all research areas and career paths which also provides travel bursaries for members to meet and study with one another. The finalists will receive personal and unlimited access to the rich content of Reaxys and Reaxys Medical Chemistry, and are invited to present their research at the Reaxys PhD Prize Symposium; where the three winners will each receive $2,000 in prize money.

The deadline for submissions is February 8, 2016. After this date, submissions will be reviewed for: originality, innovation, importance and applicability of the research; the rigor of approach and methodology; the quality and clarity of published work; and supporting evidence of these accomplishments from the recommendation letter and CV. This process is managed by a board of internationally renowned chemists. The board will subsequently select the 45 finalists. These finalists will be invited to attend the 2016 Reaxys PhD Prize Symposium, where all finalists will have the opportunity to meet and share their research.

“Every year we are impressed by the quality of entries to the Reaxys PhD Prize, and I am sure 2016 will be no exception,” said Dr. David Evans, Scientific Affairs Director at Reed Elsevier Properties SA. “In six years we have received nearly 2500 submissions from across the globe. The Prize is an opportunity to identify and support some of the brightest minds in the youngest generation of research chemists, and entry to the PhD Prize Club, helps all 45 finalists network and share knowledge giving them a running start to their chemistry careers.”

Read more about the 2016 Reaxys PhD Prize on Elsevier Connect.

For more information about the Reaxys PhD Prize and to submit an entry, go to

Reaxys empowers chemistry research and development by providing structure, property and reaction data, experimental procedures and literature. It is designed to support early drug discovery, education, material selection and synthesis planning; its capabilities include data export and integration to enable harmonized analysis of in-house and external data. Reaxys improves R&D productivity by delivering the facts the way chemists need them. For more information about Reaxys visit  


About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries.

Media Contact
Christopher Capot
Director, Corporate Relations
+1 917 704 5174